Tracy Simmons Clifford

This profile gathers the share dealings of Tracy Simmons Clifford across 2 companies, led by Pernix Therapeutics Holdings, Inc. and Acorn Energy, Inc. Between 11 February 2014 and 23 June 2026, the trades on record add up to 20 filings.

On the open market, the record shows 5 purchases worth €6,549 and 7 sales worth €316k. Sales outweigh purchases by €309k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 2 share grants and 6 option exercises.

A typical purchase (the median) is worth €915. On 3 out of 5 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Ninety days after publication, 3 purchases show a median change of +16.1%, with the price up in 67% of them. They describe history only and say nothing certain about the share price ahead.

On 24 June 2026 came the latest disclosure, an option exercise in Acorn Energy, Inc. The clock since the last published purchase (12 June 2023) now reads 1,230 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.